Episode 35 - Making Digital Pathology AI Native

This episode's guests: Leo Grady

We're talking with Leo Grady, CEO of Paige, a company developing AI based solutions in digital pathology to optimize patient outcomes.

We're going to be talking about his experiences in diagnostics, radiology, pathology, and artificial intelligence.  We’ll discuss the early history of Paige, its relationship with Memorial Sloan Kettering, what products Paige is developing, what the future holds, and their strategy for developing partnerships.

It’s been said that radiology is at least a decade ahead of pathology in terms of going digital but is this accurate and fair? Radiology images, after all, are digitally native whereas pathology images are not. What do we mean by digitally native?  What do we mean by AI native? Is it possible to create an AI native environment in digital pathology?


More About Leo Grady

Leo Grady joined Paige as CEO in 2019. He has more than 15 years of experience developing and commercializing advanced machine learning, computer vision, and diagnostic imaging technologies that have made a significant impact on medical practice. Under Leo’s leadership, Paige received FDA clearance for its FullFocus™ digital pathology viewer and CE marks for Paige Prostate and Paige Breast, its first-in-class prostate cancer and breast cancer detection solution, respectively. Previously, Grady was Senior Vice President of Engineering and Product at HeartFlow and served in various scientific and leadership roles at Siemens. Grady was inducted as a Fellow in the American Institute for Medical and Biological Engineering in 2014. In 2012, he received the Edison Patent Award in medical imaging. He received a Ph.D. in Cognitive and Neural Systems from Boston University and a B.Sc. in Electrical Engineering at the University of Vermont.